Breakthrough Paper Outlines Path to Heart Regeneration After Cardiac Injury
Cardiovascular disease kills more than 650,000 Americans annually. Those who survive myocardial infarction remain at risk of death because the human heart has a very limited ability to repair itself. No one has yet found a method that leads to cardiovascular regeneration for a damaged human heart. But all that may change thanks to a revolutionary medical paper written by Dr. Ian White, president and CSO of UF Innovate | Sid Martin Biotech resident Neobiosis, a company that focuses on the science of regenerative medicine.
Florida High Tech Corridor Incubators Experience Startup Surge
Florida native and CEO of Agriculture Intelligence Matt Donovan has discovered a “renewed environment with a fertile ground for talent.” A resident company in UF Innovate | The Hub, Agriculture Intelligence is a precision agriculture science company combining machine vision, machine learning and artificial intelligence to provide cloud-based, precision data for specialty crops.
AGTC Licenses Promoter Technology to SparingVision SAS
UF startup and UF Innovate | Sid Martin Biotech alum Applied Genetic Technologies Corporation (AGTC), a biotechnology company conducting human clinical trials of adeno-associated virus (AAV)-based gene therapies for the treatment of rare diseases, announced a licensing agreement that provides its proprietary cone-specific promoter technology to SparingVision SAS, a genomic medicine company developing vision-saving treatments for ocular diseases.
‘One Billion Doses On Day One’: Vaccine Company Claims World-Changing Innovation
Curious about what motivates the company that just acquired UF startup and UF Innovate | Sid Martin Biotech graduate Ology Bioservices? Anger at the length of time it is taking to get vaccines to fight Covid. This story in Forbes is a picture of Resilience, a new player in the town of Alachua.
Morphogenesis’ Skin Cancer Vaccine Gets FDA ‘Fast Track’
Tampa company Morphogenesis, a UF startup, has received a “fast track” designation for its skin cancer vaccination from the United States Food and Drug Administration.
Resilience Acquires Biologics Manufacturing Company Ology Bioservices
Resilience, a company building the world’s most advanced biopharmaceutical manufacturing ecosystem, announced it has acquired Ology Bioservices, Inc., a privately held company that also specializes in biologic drug substance manufacturing from early-stage through commercial products.
Sid Martin Biotech Alum DiaCarta’s Biomarker Algorithm Predicts Response and Outcome of Chemotherapy
UF Innovate | Sid Martin Biotech alum DiaCarta Inc., a precision molecular diagnostics company with proprietary technologies for the development of novel liquid biopsy oncology tests, announced the publication of a study in Nature Scientific Reports that demonstrates the company’s cfDNA biomarker algorithm could function as a prognostic biomarker and efficacy predictor for non-small cell lung cancer (NSCLC) patients.
TeamedOn and AGTC Announce a Licensing Agreement Advancing X-Linked Retinoschisis Gene Therapy Program
AGTC will provide TeamedOn with the clinical trial material, pre-clinical and clinical data generated for the development of AGTC’s investigational intravitreal gene therapy candidate, rAAV2tYF-CB-hRS1
Concept Companies Developing Momentum Labs Biotech Facility
Momentum Labs in Alachua will be the next step for companies graduating from Sid Martin Biotech that need more time before investing in their own space and equipment.
UF Innovate’s Jim O’Connell Featured on Technology Transfer IP Podcast
Jim O’Connell, assistant vice president for Commercialization at UF Innovate is featured on Tech Transfer IP Forum Podcast, a space devoted to providing in-depth analysis of intellectual property issues related to university and non-profit technology transfer.